HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

BXL628

a calcitriol analog for Inhibition of prostate cell growth; in phase II clinical trial in patients with benign prostate hyperplasia (4/2004)
Also Known As:
BXL-628; Elocalcitol
Networked: 20 relevant articles (6 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Colli, Enrico: 8 articles (07/2012 - 02/2005)
2. Adorini, Luciano: 7 articles (04/2009 - 02/2005)
3. Maggi, Mario: 7 articles (04/2009 - 02/2005)
4. Andersson, Karl-Erik: 4 articles (07/2012 - 02/2005)
5. Adorini, L: 4 articles (06/2010 - 04/2004)
6. Amuchastegui, Susana: 4 articles (04/2009 - 07/2005)
7. Morelli, Annamaria: 4 articles (04/2009 - 02/2005)
8. Fibbi, Benedetta: 4 articles (04/2009 - 02/2005)
9. Maggi, M: 3 articles (06/2010 - 04/2004)
10. Vannelli, Gabriella Barbara: 3 articles (04/2009 - 02/2005)

Related Diseases

1. Prostatitis
2. Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
3. Overactive Urinary Bladder (Overactive Bladder)
4. Male Infertility (Male Sterility)
5. Hyperplasia

Related Drugs and Biologics

1. Interleukin-8 (Interleukin 8)
2. Calcitriol Receptors (Calcitriol Receptor)
3. rho-Associated Kinases
4. Dexamethasone (Maxidex)
5. Finasteride (Propecia)
6. Vitamin D
7. tamsulosin (Flomax)
8. Cholecalciferol (Vitamin D3)
9. BXL628
10. Calcitriol (Calcijex)

Related Therapies and Procedures

1. Investigational Therapies (Experimental Therapy)